Myocardial Remodeling in Early Chronic Kidney Disease-Mineral and Bone Disorder Model with Low Bone Turnover

被引:0
|
作者
Bogdanova, Evdokia [1 ]
Sadykov, Airat [2 ]
Ivanova, Galina [3 ]
Zubina, Irina [1 ]
Beresneva, Olga [1 ]
Galkina, Olga [1 ]
Parastaeva, Marina [1 ]
Sharoyko, Vladimir [4 ]
Dobronravov, Vladimir [1 ]
机构
[1] Pavlov Univ, Res Inst Nephrol, St Petersburg 197022, Russia
[2] Pavlov Univ, Raisa Gorbacheva Mem Res Inst Pediat Oncol Hematol, St Petersburg 197022, Russia
[3] Physiol Pavlov Inst Physiol, Lab Cardiovasc & Lymphat Syst, St Petersburg 199034, Russia
[4] Pavlov Univ, Dept Gen & Bioorgan Chem, St Petersburg 197022, Russia
来源
KIDNEY AND DIALYSIS | 2023年 / 3卷 / 04期
基金
俄罗斯基础研究基金会;
关键词
chronic kidney disease-mineral and bone disorder; myocardial remodeling; phosphate; calcineurin; ERK1/2; PiT-2; Jagged1; Patched; 1; Hes1; Lgr4; LEFT-VENTRICULAR HYPERTROPHY; MAGNETIC-RESONANCE-SPECTROSCOPY; UREMIC CARDIOMYOPATHY; MOLECULAR-MECHANISMS; GENE-EXPRESSION; RENAL-FAILURE; PHOSPHATE; FIBROSIS; PATHWAY; OPPORTUNITIES;
D O I
10.3390/kidneydial3040028
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease-mineral and bone disorder (CKD-MBD) plays a significant role in causing cardiovascular morbidity and mortality related to CKD. CKD-MBD has been studied during advanced stages when changes in inorganic phosphate (Pi) and its hormonal regulation are obvious. The initial phases of myocardial remodeling (MR) in early CKD-MBD remain poorly understood. We induced mild CKD-MBD in spontaneously hypertensive rats using 3/4 nephrectomy. Animals were fed standard chow, containing 0.6% phosphate. In each animal, we analyzed indices of chronic kidney injury, bone turnover and Pi exchange, and assessed the myocardial histology and gene expression profile. Applied CKD-MBD models corresponded to human CKD S1-2 with low bone turnover and without an increase in systemic Pi-regulating factors (parathyroid hormone and fibroblast growth factor 23). In mild CKD-MBD models, we found MR features characterized by cardiomyocyte hypertrophy, interstitial and perivascular fibrosis, intramyocardial artery media thickening, along with alterations in Ppp3ca, Mapk1, Jag1, Hes1, Ptch1, Numb, Lgr4 and Bmp4 genes. Among other genes, the down-regulation of Jag1 was most tightly associated with either myocardial hypertrophy or fibrosis. Myocardial alterations concurrently occurred with mild CKD-MBD and comprised fibrosis preceding cardiomyocyte hypertrophy. The histological features of MR were associated with myocardial P accumulation in settings of low bone turnover, prior to a response of systemic Pi-regulating factors and with alterations in calcineurin, ERK1/2, Notch, BMP and Hedgehog genes.
引用
收藏
页码:322 / 334
页数:13
相关论文
共 50 条
  • [31] Circadian rhythms of mineral metabolism in chronic kidney disease-mineral bone disorder
    Egstrand, Soren
    Olgaard, Klaus
    Lewin, Ewa
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (04): : 367 - 377
  • [32] Chronic Kidney Disease-Mineral Bone Disorder: Definitions and Rationale for a Systemic Disorder
    Kiattisunthorn, Kraiwiporn
    Moe, Sharon M.
    CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM, 2012, 10 (03): : 119 - 127
  • [33] Chronic Kidney Disease-Mineral Bone Disorder: Definitions and Rationale for a Systemic Disorder
    Kraiwiporn Kiattisunthorn
    Sharon M. Moe
    Clinical Reviews in Bone and Mineral Metabolism, 2012, 10 (3): : 119 - 127
  • [34] The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease
    Graciolli, Fabiana G.
    Neves, Katia R.
    Barreto, Fellype
    Barreto, Daniela V.
    dos Reis, Luciene M.
    Canziani, Maria E.
    Sabbagh, Yves
    Carvalho, Aluizio B.
    Jorgetti, Vanda
    Elias, Rosilene M.
    Schiavi, Susan
    Moyses, Rosa M. A.
    KIDNEY INTERNATIONAL, 2017, 91 (06) : 1436 - 1446
  • [35] Current therapeutic approach of chronic kidney disease-mineral and bone disorder
    Zaimi, Maria
    Grapsa, Eirini
    THERAPEUTIC APHERESIS AND DIALYSIS, 2024, 28 (05) : 671 - 689
  • [36] THE ASSOCIATION OF CHRONIC KIDNEY DISEASE-MINERAL BONE DISORDER AND CARDIOVASCULAR RISK
    Eddington, Helen
    Kalra, Philip A.
    JOURNAL OF RENAL CARE, 2010, 36 : 61 - 67
  • [37] Effects of parathyroidectomy on bone remodeling markers and vitamin D status in patients with chronic kidney disease-mineral and bone disorder
    Emo Peters, Barbara Santarosa
    Affonso Moyses, Rosa Maria
    Jorgetti, Vanda
    Martini, Ligia Araujo
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2007, 39 (04) : 1251 - 1256
  • [38] Chronic kidney disease-mineral bone disorder and fractures in predialysis patients
    Fernandes, Bernardo
    Lopes, Mariana Diz
    Neto, Ricardo
    Frazao, Joao M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [39] Treatment of chronic kidney disease-mineral bone disorder and vascular complications
    Moe, Sharon M.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2006, 10 : S2 - S15
  • [40] Role of sclerostin in the pathogenesis of chronic kidney disease-mineral bone disorder
    Asamiya Y.
    Tsuchiya K.
    Nitta K.
    Renal Replacement Therapy, 2 (1) : 1 - 8